Results 231 to 240 of about 234,802 (359)
Mass Spectrometric Studies on Bile Acids and Other Steroid Derivatives. [PDF]
Sune Bergström+5 more
openalex +1 more source
The graphical abstract shows the principal results of this study. Eight major aroma‐contributing compounds (nonanal, octanal, dimethyl tetrasulfide, hexanal, 1‐octen‐3‐ol, (E)‐2‐nonenal, heptanal, and (E,E)‐2,4‐decadienal) were identified by electronic nose and GC‐O‐MS analysis, and their content increased with age.
Yanke Wang+6 more
wiley +1 more source
Carcinogenic and anticancer activities of microbiota-derived secondary bile acids. [PDF]
Kouhzad M+7 more
europepmc +1 more source
A Method for Spectrophotometric Determination of Chenodeoxycholic Acid in Bile. [PDF]
Björn Isaksson+3 more
openalex +1 more source
Therapeutic effect of natural products on chicken coccidiosis. Abstract The intestinal tract is the main place for animals to digest food and absorb nutrients, which also serves as the first line of defense against pathogens that invade the internal environment.
Pan Chen+6 more
wiley +1 more source
Regulation of bile acids and their receptor FXR in metabolic diseases. [PDF]
Li Y, Wang L, Yi Q, Luo L, Xiong Y.
europepmc +1 more source
ABSTRACT Since cholesterol triggers many diseases, many methods have been developed for its determination. In this study, an alternative system for cholesterol determination was developed by preparing amperometric biosensors. In the development of the biosensor, Pt/polypyrrole–polystyrene sulfonate film was prepared by electropolymerization of ...
Alaa Anwer Ali Dada+3 more
wiley +1 more source
Bile acids and incretins as modulators of obesity-associated atherosclerosis. [PDF]
Kirsch A+3 more
europepmc +1 more source
Aims The aim of study was to generate quantitative data on the abundance of drug‐metabolizing enzymes and transporters (DMETs) in inflamed and non‐inflamed Crohn's disease (CD) ileum and colon, for incorporation into physiologically based pharmacokinetic (PBPK) models, enabling prediction of oral drugs' pharmacokinetics (PK) perturbation in CD patients.
Sarah Alrubia+4 more
wiley +1 more source